Article Details

StockNews.com Downgrades CTI BioPharma (NASDAQ:CTIC) to Sell - ETF Daily News

Retrieved on: 2022-11-21 07:34:40

Tags for this article:

Click the tags to see associated articles and topics

StockNews.com Downgrades CTI BioPharma (NASDAQ:CTIC) to Sell - ETF Daily News. View article details on hiswai:

Excerpt

JMP Securities increased their price target on shares of CTI BioPharma from $6.00 to $9.00 and gave the stock a “market outperform” rating in a ...

Article found on: www.etfdailynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up